Consequences of fetal growth restriction

Current Opinion in Obstetrics and Gynecology

Volumn 10, Issue 2, 1998, Pages 145-149

  Newnham, John ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE;

BRAIN FUNCTION; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; LEAN BODY WEIGHT; LOW BIRTH WEIGHT; MALNUTRITION; PRENATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW;

ADRENAL CORTEX; ADULT; BIRTH WEIGHT; COGNITION; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION; MIDDLE AGED; NUTRITION PHYSIOLOGY; PREGNANCY;

EID: 0031897396     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199804000-00011     Document Type: Review

References (32)

1. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995; 311:171-174.
2. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993; 36:62-67.
3. Lithell HO, Mckeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. Relation of size at birth to non-insulin-dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996; 312:406-410.
4. Godfrey K, Robinson S, Barker D, Osmond C, Cox V. Maternal nutrition in early and late pregnancy in relation to placental and fetal growth. BMJ 1996; 312:410-414.
5. Godfrey KM, Barker DJP, Robinson S, Osmond C. Maternal birth-weight and diet in pregnancy in relation to the infant's thinness at birth. Br J Obstet Gynaecol 1997; 104:663-667.
6. Goldenberg RL, Cliver SP, Mulvihill FX, Hickey CA, Hoffman HJ, Kiernan LV, Johnson MJ. Medical, psychosocial, and behavioral risk factors do not explain the increased risk for low birth weight among black women. Am J Obstet Gynecol 1996: 175:1317-1324.
7. Williams LA, Evans SF, Newnham JP. Prospective cohort study of factors • influencing the relative weights of the placenta and the newborn infant. BMJ 1997; 314:1864-1868. Although there remains little doubt that low birthweight is associated with cardiovascular disease in adult life, causation has yet to be proved. This study was based on data collected prospectively from 2507 pregnancies in an ongoing cohort study in Western Australia, and determined the demographic, environmental and medical factors that influence the relative weights of the placenta and newborn infant. It was concluded that this ratio may be acting as a surrogate for other factors which are already known to influence health and may act either before or after birth.
8. Law CM, Shiell AW. Is blood pressure inversely related to birth weight? • The strength of evidence from a systematic review of the literature. J Hypertens 1996; 14:935-941. This timely article is a systematic review of all papers addressing the relationship between birthweight and blood pressure in humans. The subjects in these articles include more than 66 000 individuals aged 0-71 years and confirm a negative relationship between blood pressure and birthweight in both children and adults.
9. Moore VM, Miller AG, Boulton TJC, Cockington RA, Craig IH, Magarey • AM, Robinson JS. Placental weight, birth measurements, and blood pressure at age 8 years. Arch Dis Child 1996; 74:538-541. This retrospective study was based on a cohort of children born at term in 1975-1976 and examined at 8 years of age. It was observed that blood pressure was inversely related to birthweight and, simultaneously, positively associated with placental weight. These data build on evidence from previous animal-based and clinical studies linking fetal growth and hypertension in adult life.
10. Meaney MJ, Aitken DH, Sharma S, Viau V. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and age-related changes in hippocampal Type I and Type II corticosteroid receptor binding capacity in young and aged, handled and nonhandled rats. Neuroendocrinology 1992; 55:204-213.
11. Wajchenberg BL, Bosco A, Marone MM, Levin S, Rocha M, Lerario AC, et al. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab 1995; 80:2791-2794.
12. Whitworth JA, Brown MA, Kelly JJ, Williamson PM. Experimental studies on cortisol-induced hypertension in humans. J Human Hypertens 1995; 9:395-399.
13. Pang S, Clark AT, Freeman LC, Dolan LM, lmmken L, Mueller OT, et al. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab 1992; 75:249-253.
14. Vallee M, Mayo W, Maccari S, Le Moal M, Simon H. Long-term effects of • prenatal stress and handling on metabolic parameters: relationship to corticosterone secretion response. Brain Res 1996; 712:287-292. This study of adult rats investigated the long-term effects of prenatal and postnatal manipulations and their effects on glucocorticoid secretion. The results add to the evidence that the prenatal and postnatal environments exert long-term effects on the stress-response of the HPA axis.
15. Clark PM, Hindmarsh PC, Shiell AW, Law CM, Honour JW, Barker DJP. Size at birth and adrenocortical function in childhood. Clin Endocrinol 1996; 45:721-726.
16. Economides DL, Nicolaides KH, Linton EA, Perry LA, Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther 1988; 3:158-164.
17. Liggins GC. Premature delivery of fetal lambs infused with glucocorticoids. J Endocrinol 1969; 45:515-523.
18. Crowley P. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972-1994. Am J Obstet Gynecol 1995; 173:322-335.
19. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive • prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997; 156:178-184. This study was performed to evaluate the effects in sheep of the repeated maternal administration of corticosteroids for the purpose of enhancing lung maturation before preterm birth. Repeated doses of corticosteroids resulted in progressive improvements in postnatal lung function, but also caused fetal growth restriction. Exposure of the fetus to excessive cortisol and other stress hormones is one of the possible mechanisms by which low birthweight is associated with postnatal hypertension, obesity and diabetes.
20. Mari G, Abuhamad AZ, Keller M, Verpairojkit B, Ment L, Copel JA. Is the fetal brain-sparing effect a risk factor for the development of intraventricular hemorrhage in the preterm infant? Ultrasound Obstet Gynecol 1996; 8:329-332.
21. Scherjon SA, Oosting H, Ongerboer de Visser BW, de Wilde T, • Zondervan HA, Kok JH. Fetal brain sparing is associated with accelerated shortening of visual evoked potential latencies dunng early infancy. Am J Obstet Gynecol 1996; 175:1569-1575. This study was designed to assess the effect that fetal growth restriction exerts on myelination of the developing brain. During infancy, myelination can be assessed by the measurement of visual evoked potential latencies. Infants who had been shown in fetal life to have asymmetric growth restriction were observed at 6 months age to have accelerated neurophysiological maturation. Ongoing study of these children is required to determine the significance of this finding.
22. Martyn CN, Gale CR, Sayer AA, Fall C. Growth in utero and cognitive • function in adult life: follow-up study of people born between 1920 and 1943. BMJ 1996; 312:1393-1396. This study from the MRC Environmental Epidemiology Unit in Southampton, UK, involved the measurement of intelligence, and the decline in intelligence which occurs with age, in 1576 men and women born between 1929 and 1943. Low birthweight was not associated with poorer cognitive performance in adult life.
23. Nelson KB. Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants. JAMA 1996; 276:1843-1844.
24. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95:263-269.
25. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 1996; 276:1805-1810.
26. Grant A, Penn ZJ, Steer PJ. Elective or selective caesarean delivery of the small baby? A systematic review of the controlled trials. Br J Obstet Gynaecol 1996; 103:1197-1200.
27. The GRIT Study Group. When do obstetricians recommend delivery for a high-risk preterm growth-retarded fetus? Eur J Obstet Gynecol Reprod Biol 1996; 67:121-126.
28. Tyson JE, Broyles RS. Progress in assessing the long-term outcome of extremely low-birth-weight infants. JAMA 1996; 276:492-493.
29. Ellard GA, Johnstone FD, Prescott RJ, Ji-Xian W, Jian-Hua M. Smoking during pregnancy: the dose dependence of birthweight deficits. Br J Obstet Gynaecol 1996; 103:806-813.
30. Cnattingius S, Haglund B. Decreasing smoking prevalence during pregnancy in Sweden: the effect on small-for-gestational-age births. Am J Public Health 1997; 87:410-413.
31. Sciscione AC, Gorman R, Callan NA. Adjustment of birth weight standards for maternal and infant characteristics improves the prediction of outcome in the small-for-gestational-age infant. Am J Obstet Gynecol 1996; 175:544-547.
32. Piper JM, Langer O, Xenakis EM, McFarland M, Elliott BD, Berkus MD. Perinatal outcome in growth-restricted fetuses: do hypertensive and normotensive pregnancies differ? Obstet Gynecol 1996; 88:194-199.